Abeona Therapeutics Inc.
ABEO· Nasdaq
Released Aug 14, 2017, after the close
10-Q filed Aug 14, 2017, 45 days after period end · 0001144204-17-043141
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Revenue | $217.00K | $214.00K | $282.00K | $247.00K |
| Net Income | -$8.28M | -$6.70M | -$4.11M | -$12.51M |
| EPS Diluted | -$0.21 |
Abeona Therapeutics Inc. · CIK 318306 · Engraved from SEC EDGAR
| -$0.20 |
| -$0.16 |
| -$0.51 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.